PLAT and ischemic stroke: A randomized double-blind trial of the effect of tPA was conducted in 333 patients with ischemic stroke, demonstrating the clinical efficacy of this agent, which is mainly expressed via a reduction in disability compared to the control group members who received placebo [6].